A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM

NCT06203145 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Renal Injury

Interventions

DRUG: Bortezomib

Sponsor

Peking University First Hospital